Archives by Month:

Lorus Therapeutics Announces Positive Result in its Phase II Clinical Study of LOR-2040 in Acute Myeloid Leukemia (AML)

Tuesday, December 1st, 2009

- Efficacy and safety data supports advancement to a comparative trial as a strategy to support registration -
Read more pdf

This entry was posted in News & Events.

03.02.12: Webinar: Optimising Drug Development: Enabling quantitative decision making in drug development through simulation; Located in: Events, News & Events
31.01.12: Science Powered Technology and Consulting news from Tessella; Located in: News & Events
25.01.12: Tessella re-organises to maximise client value in 2012; Located in: News & Events
11.01.12: On demand webinar: Running Adaptive Clinical Trials: Myth and Reality; Located in: Events, News & Events
10.01.12: Press Release: Running Adaptive Clinical Trials: Myth and Reality – Free Webinar; Located in: News & Events, Press Releases
22.12.11: Austin PASIG 2012; January 11th to 13th 2012, Austin, Texas; Located in: Past Events
13.12.11: Tessella Physics Prize; Located in: News & Events
29.11.11: CEDA and Tessella collaboration brings Earth observation data to life; Located in: News & Events
: Guardian Supplement: Search and deploy; Located in: Coverage, News & Events
26.11.11: Information Retention and eDiscovery Exchange; November 14th to November 16th 2011, Munich, Germany; Located in: Past Events